local_hospital

Spitalul Clinic De Urgenta Pentru Copii Sfanta Maria Iasi

Address
lock Available on a paid plan

Spitalul Clinic De Urgenta Pentru Copii Sfanta Maria Iasi - Pediatric Research Center

Spitalul Clinic De Urgenta Pentru Copii Sfanta Maria Iasi is a specialized pediatric clinical research center in Romania with extensive experience in conducting Phase 3 clinical trials for children and adolescents. The center demonstrates particular expertise in evaluating novel therapeutic interventions across multiple pediatric conditions, focusing on pharmacokinetics, efficacy, and long-term safety outcomes in vulnerable pediatric populations.

  • Pediatric dermatology research, including moderate to severe plaque psoriasis treatments
  • Neurological disorders in children, with emphasis on absence epilepsy (childhood and juvenile) and migraine management
  • Pharmacokinetic and safety studies in diverse pediatric age groups from toddlers to young adults

The center's research portfolio includes innovative studies on deucravacitinib for plaque psoriasis, lasmiditan for pediatric migraine, and brivaracetam monotherapy for absence epilepsy. With capability to conduct trials spanning ages 2 to 25 years, the facility is equipped to evaluate both short-term efficacy and long-term safety profiles of emerging pediatric therapeutics, contributing valuable data to advance treatment options for children with chronic neurological and dermatological conditions.

Site Overview

assignment
8
connected trials
corporate_fare
5
sponsors
science
6
IMPs

Activity Indicator

Last 6 months

1
Trials started
0% vs previous period.
1
Trials started 6–12 months ago
8
Total trials linked
Active
trending_flatStable0%
1
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
3
Sponsors (total)
5
Active sponsors
3

Sponsor Network

Top 3 by active trials.

lock +2 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

lock +1 more on a paid plan

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 442 other sites in Romania

description
Trial volume
8
Outperforms 73% of sites
public
Therapeutic diversity
3areas
Outperforms 73% of sites
groups
Sponsor diversity
5sponsors
Outperforms 69% of sites

Therapeutic Area Benchmark — Romania

Select a therapeutic area to compare against other sites in Romania.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Romania

Market Share

Country: Romania

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Spitalul Clinic De Urgenta Pentru Copii Sfanta Maria Iasi

lock Showing 1 of 8 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
A Multicenter, Open-Label, Follow-Up Study to Assess the Long-Term Use of Oral Lacosamide in Study Participants Who Completed EP0034 or SP848 and Received Lacosamide TreatmentUCB BiopharmaPhase IIINot RecruitingDec 2020Feb 2025

IMP list

lock Showing 1 of 6 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Brivaracetam2Unknown2022-03-102024-11-27

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.